Work

Autologous hematopoietic stem cell transplantation followed by CD19/CD22 dual-target CAR-T therapy for refractory or relapsed burkitt lymphoma

Year: 2025
Type: conference-abstract
Source: Blood
Language: English
Subfield: Oncology
Field: Medicine
Open Access status: closed
OpenAlex ID: W4417018400
Cites:
Cited by:
Related to: